Obesity and Weight Loss in Polycystic Ovary Syndrome
Overview
Authors
Affiliations
Polycystic ovary syndrome (PCOS) and obesity are common and complicated disorders that are influenced by genetic and environmental factors. Obesity is a prominent feature of PCOS; at least 50% of patients with PCOS are obese. Obesity appears to exert an additive, synergistic effect on the manifestations of PCOS, independently impacting insulin sensitivity, risk for diabetes, and adverse cardiovascular profile. There is evidence for the benefit of weight reduction in the management of PCOS in the obese patient. Weight loss remains a primary intervention in treatment of this disorder.
Abbasi E, Hajhashemy Z, Askari G, Saneei P Clin Nutr Res. 2024; 13(3):201-213.
PMID: 39165287 PMC: 11333146. DOI: 10.7762/cnr.2024.13.3.201.
Karakaya C, Cil A, Bilguvar K, Cakir T, Karalok M, Karabacak R J Obstet Gynaecol Res. 2022; 48(5):1202-1211.
PMID: 35141985 PMC: 9050819. DOI: 10.1111/jog.15187.
Jove M, Pradas I, Naudi A, Rovira-Llopis S, Banuls C, Rocha M Oncotarget. 2018; 9(4):4522-4536.
PMID: 29435121 PMC: 5796992. DOI: 10.18632/oncotarget.23393.
Gulbay G, Yesilada E, Celik O, Yologlu S Asian Pac J Cancer Prev. 2017; 18(5):1219-1223.
PMID: 28610405 PMC: 5555526. DOI: 10.22034/APJCP.2017.18.5.1219.
Clinical characteristics in Taiwanese women with polycystic ovary syndrome.
Hsu M Clin Exp Reprod Med. 2015; 42(3):86-93.
PMID: 26473107 PMC: 4604298. DOI: 10.5653/cerm.2015.42.3.86.